M Hashimoto

1.4k total citations · 1 hit paper
20 papers, 1.1k citations indexed

About

M Hashimoto is a scholar working on Oncology, Pharmacology and Pharmacology. According to data from OpenAlex, M Hashimoto has authored 20 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pharmacology and 5 papers in Pharmacology. Recurrent topics in M Hashimoto's work include Drug Transport and Resistance Mechanisms (8 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). M Hashimoto is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). M Hashimoto collaborates with scholars based in Japan and United States. M Hashimoto's co-authors include David J. Jollow, John R. Mitchell, S S Thorgeirsson, William Z. Potter, Hisashi Miyazaki, Toshihiko Fujii, K Matsumoto, Kōji Yoshida, Takafumi Maeda and Kenji Kanenishi and has published in prestigious journals such as Cardiovascular Research, Life Sciences and Journal of Histochemistry & Cytochemistry.

In The Last Decade

M Hashimoto

20 papers receiving 1.0k citations

Hit Papers

Acetaminophen-induced Hepatic Necrosis 1974 2026 1991 2008 1974 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Hashimoto Japan 11 742 272 191 183 122 20 1.1k
L. Vereczkey Hungary 21 547 0.7× 358 1.3× 341 1.8× 112 0.6× 173 1.4× 89 1.4k
Roy L. Hawke United States 18 791 1.1× 330 1.2× 332 1.7× 162 0.9× 97 0.8× 33 1.4k
Marina Tinel France 25 795 1.1× 378 1.4× 401 2.1× 134 0.7× 114 0.9× 47 1.5k
Gilles Labbe France 21 819 1.1× 286 1.1× 469 2.5× 213 1.2× 88 0.7× 29 1.6k
Lynda Letzig United States 18 497 0.7× 152 0.6× 164 0.9× 233 1.3× 66 0.5× 24 916
Mary K. Bruno United States 9 585 0.8× 212 0.8× 135 0.7× 186 1.0× 34 0.3× 12 743
Andrew W. Harman Australia 15 496 0.7× 184 0.7× 222 1.2× 211 1.2× 42 0.3× 27 864
Steven I. Shedlofsky United States 21 373 0.5× 226 0.8× 354 1.9× 168 0.9× 107 0.9× 35 1.4k
C. Riché France 18 585 0.8× 454 1.7× 386 2.0× 50 0.3× 121 1.0× 51 1.3k
Yasuhiro Masubuchi Japan 16 598 0.8× 242 0.9× 153 0.8× 221 1.2× 55 0.5× 29 902

Countries citing papers authored by M Hashimoto

Since Specialization
Citations

This map shows the geographic impact of M Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Hashimoto more than expected).

Fields of papers citing papers by M Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Hashimoto. The network helps show where M Hashimoto may publish in the future.

Co-authorship network of co-authors of M Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of M Hashimoto. A scholar is included among the top collaborators of M Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Hashimoto. M Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hata, Toshiyuki, et al.. (1999). Maternal Circulating Nitrite Levels Are Decreased in both Normal Normotensive Pregnancies and Pregnancies with Preeclampsia. Gynecologic and Obstetric Investigation. 48(2). 93–97. 22 indexed citations
2.
Hashimoto, M, Shuji Gamoh, Shahdat Hossain, et al.. (1998). AGE‐RELATED CHANGES IN AORTIC SENSITIVITY TO NORADRENALINE AND ACETYLCHOLINE IN RATS. Clinical and Experimental Pharmacology and Physiology. 25(9). 676–681. 13 indexed citations
3.
Hashimoto, M, et al.. (1998). Changes in plasma and urinary norepinephrine following transdermal clonidine in spontaneously hypertensive rats.. PubMed. 48(8). 811–7. 2 indexed citations
4.
Kuramochi, Takehiko, Masaaki Honda, K Tanaka, et al.. (1994). Contrasting effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on calcium transients in isolated rat cardiac myocytes. Cardiovascular Research. 28(9). 1407–1413. 6 indexed citations
5.
Tanaka, Kōichi, et al.. (1994). Different effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on protein metabolism in rats with right ventricular hypertrophy. Journal of Hypertension. 12(10). 1147???1154–1147???1154. 7 indexed citations
6.
Miyazaki, Hisashi, et al.. (1991). Disposition and metabolism of [14C]sparfloxacin in the rat.. PubMed. 41(7). 747–59. 22 indexed citations
7.
Miyazaki, Hisashi, et al.. (1991). Disposition and metabolism of [14C]sparfloxacin after repeated administration in the rat.. PubMed. 41(7). 760–3. 1 indexed citations
8.
Hashimoto, M, et al.. (1990). [Clinical electrophysiological effects of nicorandil on the conduction system in humans].. PubMed. 38(7). 683–6. 3 indexed citations
9.
Yoshida, Kōji, et al.. (1988). Disposition and metabolism of [14C]-amezinium metilsulfate in rats.. PubMed. 38(7). 909–18. 1 indexed citations
10.
Matsumoto, K, et al.. (1986). Disposition and metabolism of the novel antihypertensive agent alacepril in rats.. CORROSION. 36(1). 40–6. 17 indexed citations
11.
Miyazaki, Hisashi, et al.. (1986). Excretion and metabolism of intramuscularly administered [14C]-haloperidol decanoate in rats.. PubMed. 36(3). 453–6. 7 indexed citations
12.
Miyazaki, Hisashi, et al.. (1986). Disposition and metabolism of [14C]-haloperidol in rats.. PubMed. 36(3). 443–52. 24 indexed citations
13.
Fujii, Toshihiko, et al.. (1984). [Disposition and metabolism of 14C-dehydrocorydaline in mice and rats].. PubMed. 33(8). 519–25. 6 indexed citations
14.
Matsumoto, K, et al.. (1983). Absorption, distribution and excretion of 3-(sulfamoyl[14C]methyl)-1,2-benziosoxazole (AD-810) in Rats, Dogs and Monkeys and of AD-810 in Men.. PubMed. 33(7). 961–8. 51 indexed citations
15.
Miyazaki, Hisashi, et al.. (1982). Loperamide in rat intestines: A unique disposition. Life Sciences. 30(25). 2203–2206. 11 indexed citations
17.
Katae, Hiromi, et al.. (1979). The evaluation of piromidic acid as an antibiotic in fish: an in vitro and in vivo study. Journal of Fish Diseases. 2(4). 321–335. 14 indexed citations
18.
Katae, Hiromi, et al.. (1979). Distribution, excretion and biotransformation of 14C‐piromidic acid in goldfish Carassius aumtus (L.). Journal of Fish Diseases. 2(6). 529–542. 3 indexed citations
19.
Miyazaki, Hisashi, et al.. (1978). Distribution of [14C]labeled purines in the mouse. A whole body autoradiographic assessment of purine metabolism in mammals.. Journal of Histochemistry & Cytochemistry. 26(8). 663–676. 10 indexed citations
20.
Jollow, David J., S S Thorgeirsson, William Z. Potter, M Hashimoto, & John R. Mitchell. (1974). Acetaminophen-induced Hepatic Necrosis. Pharmacology. 12(4-5). 251–271. 894 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026